搜索临床试验以:Fibroblast Growth Factor (FGF23)
总计42045个结果
-
Chinese PLA General Hospital未知Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds中国
-
Janssen Research & Development, LLC完全的
-
Institut de Recherches Internationales ServierBreast International Group完全的
-
GlaxoSmithKline完全的肿瘤美国, 丹麦, 西班牙, 比利时, 英国, 俄罗斯联邦, 荷兰
-
Janssen Research & Development, LLC完全的
-
Janssen Scientific Affairs, LLC批准上市晚期癌症和 FGFR 基因改变
-
Loughborough UniversityNottingham University Hospitals NHS Trust; Nottingham Trent University完全的
-
Astellas Pharma IncAstellas Pharma Global Development, Inc.完全的
-
Teresa Helsten, MDClovis Oncology, Inc.撤销
-
Omnia Mohammed Hashem暂停
-
Xijing HospitalXiangya Hospital of Central South University; Southwest Hospital, China; Second Affiliated Hospital... 和其他合作者未知
-
National Taiwan University Hospital未知
-
Samueli Institute for Information Biology完全的
-
Naofumi TakeharaNational Cerebral and Cardiovascular Center; Translational Research Center for Medical Innovation... 和其他合作者完全的
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., Geneva完全的
-
Merck KGaA, Darmstadt, Germany完全的
-
Instituto Nacional de Ciencias Medicas y Nutricion...完全的
-
University of Alabama at BirminghamGenentech, Inc.完全的
-
Diskapi Teaching and Research Hospital未知
-
National Institute of Dental and Craniofacial Research...完全的
-
Kaken Pharmaceutical完全的